ID   UN13A_RAT               Reviewed;        1735 AA.
AC   Q62768;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   22-JUL-2015, entry version 116.
DE   RecName: Full=Protein unc-13 homolog A;
DE   AltName: Full=Munc13-1;
GN   Name=Unc13a; Synonyms=Unc13h1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ALTERNATIVE SPLICING,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=7559667; DOI=10.1074/jbc.270.42.25273;
RA   Brose N., Hofmann K., Hata Y., Suedhof T.C.;
RT   "Mammalian homologues of Caenorhabditis elegans unc-13 gene define
RT   novel family of C2-domain proteins.";
RL   J. Biol. Chem. 270:25273-25280(1995).
RN   [2]
RP   INTERACTION WITH SYNTAXIN 1.
RX   PubMed=8999968; DOI=10.1074/jbc.272.4.2520;
RA   Betz A., Okamoto M., Benseler F., Brose N.;
RT   "Direct interaction of the rat unc-13 homologue Munc13-1 with the N
RT   terminus of syntaxin.";
RL   J. Biol. Chem. 272:2520-2526(1997).
RN   [3]
RP   INTERACTION WITH DOC2A.
RX   PubMed=9195900; DOI=10.1074/jbc.272.26.16081;
RA   Orita S., Naito A., Sakaguchi G., Maeda M., Igarashi H., Sasaki T.,
RA   Takai Y.;
RT   "Physical and functional interactions of Doc2 and Munc13 in Ca2+-
RT   dependent exocytotic machinery.";
RL   J. Biol. Chem. 272:16081-16084(1997).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF HIS-567.
RX   PubMed=9697857; DOI=10.1016/S0896-6273(00)80520-6;
RA   Betz A., Ashery U., Rickmann M., Augustin I., Neher E., Suedhof T.C.,
RA   Rettig J., Brose N.;
RT   "Munc13-1 is a presynaptic phorbol ester receptor that enhances
RT   neurotransmitter release.";
RL   Neuron 21:123-136(1998).
RN   [5]
RP   INTERACTION WITH DOC2A.
RX   PubMed=9736751; DOI=10.1073/pnas.95.19.11418;
RA   Mochida S., Orita S., Sakaguchi G., Sasaki T., Takai Y.;
RT   "Role of the Doc2 alpha-Munc13-1 interaction in the neurotransmitter
RT   release process.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:11418-11422(1998).
RN   [6]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=9895278; DOI=10.1042/0264-6021:3370363;
RA   Augustin I., Betz A., Herrmann C., Jo T., Brose N.;
RT   "Differential expression of two novel Munc13 proteins in rat brain.";
RL   Biochem. J. 337:363-371(1999).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH RIMS1.
RX   PubMed=11343654; DOI=10.1016/S0896-6273(01)00272-0;
RA   Betz A., Thakur P., Junge H.J., Ashery U., Rhee J.S., Scheuss V.,
RA   Rosenmund C., Rettig J., Brose N.;
RT   "Functional interaction of the active zone proteins Munc13-1 and RIM1
RT   in synaptic vesicle priming.";
RL   Neuron 30:183-196(2001).
RN   [8]
RP   FUNCTION.
RX   PubMed=11792326; DOI=10.1016/S0092-8674(01)00635-3;
RA   Rhee J.S., Betz A., Pyott S., Reim K., Varoqueaux F., Augustin I.,
RA   Hesse D., Suedhof T.C., Takahashi M., Rosenmund C., Brose N.;
RT   "Beta phorbol ester- and diacylglycerol-induced augmentation of
RT   transmitter release is mediated by Munc13s and not by PKCs.";
RL   Cell 108:121-133(2002).
RN   [9]
RP   INTERACTION WITH BSN, AND IDENTIFICATION IN A COMPLEX WITH ERC2 AND
RP   RIMS1.
RX   PubMed=12163476; DOI=10.1083/jcb.200202083;
RA   Ohtsuka T., Takao-Rikitsu E., Inoue E., Inoue M., Takeuchi M.,
RA   Matsubara K., Deguchi-Tawarada M., Satoh K., Morimoto K.,
RA   Nakanishi H., Takai Y.;
RT   "Cast: a novel protein of the cytomatrix at the active zone of
RT   synapses that forms a ternary complex with RIM1 and Munc13-1.";
RL   J. Cell Biol. 158:577-590(2002).
RN   [10]
RP   TISSUE SPECIFICITY.
RX   PubMed=12871971; DOI=10.1074/jbc.M303203200;
RA   Sheu L., Pasyk E.A., Ji J., Huang X., Gao X., Varoqueaux F., Brose N.,
RA   Gaisano H.Y.;
RT   "Regulation of insulin exocytosis by Munc13-1.";
RL   J. Biol. Chem. 278:27556-27563(2003).
RN   [11]
RP   INTERACTION WITH BSN.
RX   PubMed=14734538; DOI=10.1083/jcb.200307101;
RA   Takao-Rikitsu E., Mochida S., Inoue E., Deguchi-Tawarada M., Inoue M.,
RA   Ohtsuka T., Takai Y.;
RT   "Physical and functional interaction of the active zone proteins,
RT   CAST, RIM1, and Bassoon, in neurotransmitter release.";
RL   J. Cell Biol. 164:301-311(2004).
RN   [12]
RP   DOMAIN, AND MUTAGENESIS OF GLN-1190; LEU-1279; ILE-1364; VAL-1603 AND
RP   ASP-1655.
RX   PubMed=16271475; DOI=10.1016/j.cub.2005.10.055;
RA   Stevens D.R., Wu Z.-X., Matti U., Junge H.J., Schirra C., Becherer U.,
RA   Wojcik S.M., Brose N., Rettig J.;
RT   "Identification of the minimal protein domain required for priming
RT   activity of Munc13-1.";
RL   Curr. Biol. 15:2243-2248(2005).
RN   [13]
RP   INTERACTION WITH RIMS2.
RX   PubMed=16052212; DOI=10.1038/sj.emboj.7600753;
RA   Dulubova I., Lou X., Lu J., Huryeva I., Alam A., Schneggenburger R.,
RA   Suedhof T.C., Rizo J.;
RT   "A Munc13/RIM/Rab3 tripartite complex: from priming to plasticity?";
RL   EMBO J. 24:2839-2850(2005).
RN   [14]
RP   INTERACTION WITH RIMS1, AND MUTAGENESIS OF THR-22; TYR-23; VAL-64;
RP   HIS-119 AND ILE-121.
RX   PubMed=16704978; DOI=10.1074/jbc.M601421200;
RA   Andrews-Zwilling Y.S., Kawabe H., Reim K., Varoqueaux F., Brose N.;
RT   "Binding to Rab3A-interacting molecule RIM regulates the presynaptic
RT   recruitment of Munc13-1 and ubMunc13-2.";
RL   J. Biol. Chem. 281:19720-19731(2006).
RN   [15]
RP   STRUCTURE BY NMR OF 567-616.
RX   PubMed=15667202; DOI=10.1021/bi0476127;
RA   Shen N., Guryev O., Rizo J.;
RT   "Intramolecular occlusion of the diacylglycerol-binding site in the C1
RT   domain of munc13-1.";
RL   Biochemistry 44:1089-1096(2005).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.44 ANGSTROMS) OF 1-128, AND X-RAY
RP   CRYSTALLOGRAPHY (1.78 ANGSTROMS) OF 2-150 IN COMPLEX WITH RIMS2.
RX   PubMed=16732694; DOI=10.1371/journal.pbio.0040192;
RA   Lu J., Machius M., Dulubova I., Dai H., Suedhof T.C., Tomchick D.R.,
RA   Rizo J.;
RT   "Structural basis for a Munc13-1 homodimer to Munc13-1/RIM heterodimer
RT   switch.";
RL   PLoS Biol. 4:1159-1172(2006).
CC   -!- FUNCTION: Plays a role in vesicle maturation during exocytosis as
CC       a target of the diacylglycerol second messenger pathway. Involved
CC       in neurotransmitter release by acting in synaptic vesicle priming
CC       prior to vesicle fusion and participates in the activity-dependent
CC       refilling of readily releasable vesicle pool (RRP). Essential for
CC       synaptic vesicle maturation in most excitatory/glutamatergic but
CC       not inhibitory/GABA-mediated synapses. Also involved in secretory
CC       granule priming in insulin secretion.
CC       {ECO:0000269|PubMed:11343654, ECO:0000269|PubMed:11792326,
CC       ECO:0000269|PubMed:9697857}.
CC   -!- SUBUNIT: Interacts with the N-termini of STX1A and/or STX1B1 and
CC       DOC2A. Interacts with BSN. Interacts with RIMS1 which recruits
CC       UNC13A to the active zone. Forms homodimers via its first C2
CC       domain. Also interacts via this domain with the zinc finger domain
CC       of RIMS2. Part of a complex consisting of ERC2, RIMS1 and UNC13A.
CC       Also part of a complex consisting of UNC13A, RIMS2 and RAB3A.
CC       Interacts with FBXO45 (via SRY domain); leading to the degradation
CC       of UNC13A by the proteasome (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cell membrane; Peripheral
CC       membrane protein. Cell junction, synapse, presynaptic cell
CC       membrane; Peripheral membrane protein. Note=Localized to the
CC       active zone of presynaptic density. Translocated to the plasma
CC       membrane in response to phorbol ester binding.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q62768-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q62768-2; Sequence=VSP_011382;
CC       Name=3;
CC         IsoId=Q62768-3; Sequence=VSP_011383;
CC   -!- TISSUE SPECIFICITY: Expressed in brain, with highest levels in the
CC       olfactory bulb, striatum, cerebral cortex, hippocampus and
CC       cerebellum. Also expressed in pancreatic islet cells.
CC       {ECO:0000269|PubMed:12871971, ECO:0000269|PubMed:7559667,
CC       ECO:0000269|PubMed:9895278}.
CC   -!- DEVELOPMENTAL STAGE: First detected at birth, after which
CC       expression level is steadily increasing until it reaches a plateau
CC       at P15. {ECO:0000269|PubMed:9895278}.
CC   -!- DOMAIN: The C2 domains are not involved in calcium-dependent
CC       phospholipid binding. {ECO:0000269|PubMed:16271475}.
CC   -!- DOMAIN: The C-terminal region containing both MHD domains and the
CC       third C2 domain is required for synaptic vesicle priming activity.
CC       {ECO:0000269|PubMed:16271475}.
CC   -!- SIMILARITY: Belongs to the unc-13 family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 3 C2 domains. {ECO:0000255|PROSITE-
CC       ProRule:PRU00041}.
CC   -!- SIMILARITY: Contains 1 MHD1 (MUNC13 homology domain 1) domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00587}.
CC   -!- SIMILARITY: Contains 1 MHD2 (MUNC13 homology domain 2) domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00588}.
CC   -!- SIMILARITY: Contains 1 phorbol-ester/DAG-type zinc finger.
CC       {ECO:0000255|PROSITE-ProRule:PRU00226}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U24070; AAC52266.1; -; mRNA.
DR   PIR; A57607; A57607.
DR   RefSeq; NP_074052.1; NM_022861.1. [Q62768-1]
DR   UniGene; Rn.10126; -.
DR   PDB; 1Y8F; NMR; -; A=567-616.
DR   PDB; 2CJS; X-ray; 1.78 A; A/B=2-150.
DR   PDB; 2CJT; X-ray; 1.44 A; A/B/C/D=1-128.
DR   PDB; 2KDU; NMR; -; B=458-492.
DR   PDB; 3KWT; X-ray; 1.89 A; A=675-820.
DR   PDB; 3KWU; X-ray; 1.37 A; A=675-820.
DR   PDB; 3SWH; X-ray; 2.65 A; A/B=1148-1407, A/B=1453-1531.
DR   PDBsum; 1Y8F; -.
DR   PDBsum; 2CJS; -.
DR   PDBsum; 2CJT; -.
DR   PDBsum; 2KDU; -.
DR   PDBsum; 3KWT; -.
DR   PDBsum; 3KWU; -.
DR   PDBsum; 3SWH; -.
DR   ProteinModelPortal; Q62768; -.
DR   SMR; Q62768; 2-128, 567-616.
DR   DIP; DIP-29191N; -.
DR   STRING; 10116.ENSRNOP00000025162; -.
DR   PhosphoSite; Q62768; -.
DR   PaxDb; Q62768; -.
DR   PRIDE; Q62768; -.
DR   GeneID; 64829; -.
DR   KEGG; rno:64829; -.
DR   CTD; 23025; -.
DR   RGD; 619722; Unc13a.
DR   eggNOG; NOG245727; -.
DR   HOVERGEN; HBG057340; -.
DR   InParanoid; Q62768; -.
DR   KO; K15293; -.
DR   PhylomeDB; Q62768; -.
DR   EvolutionaryTrace; Q62768; -.
DR   NextBio; 613746; -.
DR   PRO; PR:Q62768; -.
DR   Proteomes; UP000002494; Unplaced.
DR   Genevisible; Q62768; RN.
DR   GO; GO:0030054; C:cell junction; IEA:UniProtKB-KW.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0060076; C:excitatory synapse; IDA:BHF-UCL.
DR   GO; GO:0043005; C:neuron projection; IDA:RGD.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:RGD.
DR   GO; GO:0043234; C:protein complex; IDA:RGD.
DR   GO; GO:0043195; C:terminal bouton; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0019992; F:diacylglycerol binding; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019904; F:protein domain specific binding; IDA:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:RGD.
DR   GO; GO:0047485; F:protein N-terminus binding; IPI:RGD.
DR   GO; GO:0000149; F:SNARE binding; IDA:RGD.
DR   GO; GO:0030507; F:spectrin binding; IPI:RGD.
DR   GO; GO:0017075; F:syntaxin-1 binding; IPI:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   GO; GO:0060291; P:long-term synaptic potentiation; IMP:RGD.
DR   GO; GO:0007269; P:neurotransmitter secretion; IDA:RGD.
DR   GO; GO:0016082; P:synaptic vesicle priming; IDA:RGD.
DR   Gene3D; 2.60.40.150; -; 3.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR010439; Ca-dep_secretion_activator.
DR   InterPro; IPR014770; Munc13_1.
DR   InterPro; IPR014772; Munc13_dom-2.
DR   InterPro; IPR019558; Munc13_subgr_dom-2.
DR   InterPro; IPR002219; PE/DAG-bd.
DR   InterPro; IPR027080; Unc-13.
DR   PANTHER; PTHR10480; PTHR10480; 1.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF00168; C2; 3.
DR   Pfam; PF06292; DUF1041; 1.
DR   Pfam; PF10540; Membr_traf_MHD; 1.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00239; C2; 3.
DR   SUPFAM; SSF49562; SSF49562; 3.
DR   PROSITE; PS50004; C2; 2.
DR   PROSITE; PS51258; MHD1; 1.
DR   PROSITE; PS51259; MHD2; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell membrane;
KW   Coiled coil; Complete proteome; Cytoplasm; Exocytosis; Membrane;
KW   Metal-binding; Reference proteome; Repeat; Synapse; Zinc; Zinc-finger.
FT   CHAIN         1   1735       Protein unc-13 homolog A.
FT                                /FTId=PRO_0000188574.
FT   DOMAIN        1     79       C2 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   DOMAIN      676    782       C2 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   DOMAIN     1106   1249       MHD1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00587}.
FT   DOMAIN     1358   1525       MHD2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00588}.
FT   DOMAIN     1564   1691       C2 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00041}.
FT   ZN_FING     566    616       Phorbol-ester/DAG-type.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00226}.
FT   COILED      319    370       {ECO:0000255}.
FT   COMPBIAS    320    452       Glu-rich.
FT   METAL       580    580       Zinc 1.
FT   METAL       583    583       Zinc 1.
FT   METAL       597    597       Zinc 2.
FT   METAL       600    600       Zinc 2.
FT   METAL       608    608       Zinc 1.
FT   METAL       616    616       Zinc 2.
FT   VAR_SEQ    1434   1456       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_011382.
FT   VAR_SEQ    1541   1559       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_011383.
FT   MUTAGEN      22     22       T->I: No effect on binding to RIMS1.
FT                                {ECO:0000269|PubMed:16704978}.
FT   MUTAGEN      23     23       Y->N: No effect on binding to RIMS1.
FT                                {ECO:0000269|PubMed:16704978}.
FT   MUTAGEN      64     64       V->M: No effect on binding to RIMS1.
FT                                {ECO:0000269|PubMed:16704978}.
FT   MUTAGEN     119    119       H->R: No effect on binding to RIMS1.
FT                                {ECO:0000269|PubMed:16704978}.
FT   MUTAGEN     121    121       I->N: Abolishes binding to RIMS1.
FT                                {ECO:0000269|PubMed:16704978}.
FT   MUTAGEN     567    567       H->K: Loss of phorbol-ester binding.
FT                                {ECO:0000269|PubMed:9697857}.
FT   MUTAGEN    1190   1190       Q->R: Loss of binding to STX1B and
FT                                priming activity; when associated with P-
FT                                1279 and E-1655.
FT                                {ECO:0000269|PubMed:16271475}.
FT   MUTAGEN    1279   1279       L->P: Loss of binding to STX1B and
FT                                priming activity; when associated with R-
FT                                1190 and E-1655.
FT                                {ECO:0000269|PubMed:16271475}.
FT   MUTAGEN    1364   1364       I->F: Loss of binding to STX1B and
FT                                priming activity.
FT                                {ECO:0000269|PubMed:16271475}.
FT   MUTAGEN    1603   1603       V->D: Loss of binding to STX1B and
FT                                priming activity.
FT                                {ECO:0000269|PubMed:16271475}.
FT   MUTAGEN    1655   1655       D->E: Loss of binding to STX1B and
FT                                priming activity; when associated with R-
FT                                1190 and P-1279.
FT                                {ECO:0000269|PubMed:16271475}.
FT   STRAND        2     12       {ECO:0000244|PDB:2CJT}.
FT   HELIX        17     19       {ECO:0000244|PDB:2CJT}.
FT   STRAND       21     28       {ECO:0000244|PDB:2CJT}.
FT   STRAND       31     34       {ECO:0000244|PDB:2CJT}.
FT   STRAND       38     42       {ECO:0000244|PDB:2CJT}.
FT   STRAND       44     53       {ECO:0000244|PDB:2CJT}.
FT   STRAND       57     66       {ECO:0000244|PDB:2CJT}.
FT   STRAND       72     81       {ECO:0000244|PDB:2CJT}.
FT   HELIX        82     84       {ECO:0000244|PDB:2CJT}.
FT   STRAND       95     98       {ECO:0000244|PDB:2CJT}.
FT   STRAND      102    106       {ECO:0000244|PDB:2CJT}.
FT   STRAND      109    111       {ECO:0000244|PDB:2CJT}.
FT   STRAND      120    128       {ECO:0000244|PDB:2CJT}.
FT   HELIX       135    150       {ECO:0000244|PDB:2CJS}.
FT   HELIX       459    478       {ECO:0000244|PDB:2KDU}.
FT   HELIX       487    490       {ECO:0000244|PDB:2KDU}.
FT   STRAND      569    573       {ECO:0000244|PDB:1Y8F}.
FT   TURN        581    583       {ECO:0000244|PDB:1Y8F}.
FT   STRAND      593    597       {ECO:0000244|PDB:1Y8F}.
FT   TURN        598    600       {ECO:0000244|PDB:1Y8F}.
FT   HELIX       608    611       {ECO:0000244|PDB:1Y8F}.
FT   STRAND      689    700       {ECO:0000244|PDB:3KWU}.
FT   STRAND      712    718       {ECO:0000244|PDB:3KWU}.
FT   STRAND      721    724       {ECO:0000244|PDB:3KWU}.
FT   STRAND      735    744       {ECO:0000244|PDB:3KWU}.
FT   STRAND      750    757       {ECO:0000244|PDB:3KWU}.
FT   HELIX       762    767       {ECO:0000244|PDB:3KWU}.
FT   TURN        768    770       {ECO:0000244|PDB:3KWU}.
FT   STRAND      774    784       {ECO:0000244|PDB:3KWU}.
FT   HELIX       785    787       {ECO:0000244|PDB:3KWU}.
FT   STRAND      790    797       {ECO:0000244|PDB:3KWU}.
FT   STRAND      810    818       {ECO:0000244|PDB:3KWU}.
FT   HELIX      1159   1187       {ECO:0000244|PDB:3SWH}.
FT   STRAND     1192   1195       {ECO:0000244|PDB:3SWH}.
FT   HELIX      1201   1218       {ECO:0000244|PDB:3SWH}.
FT   HELIX      1224   1256       {ECO:0000244|PDB:3SWH}.
FT   HELIX      1263   1285       {ECO:0000244|PDB:3SWH}.
FT   TURN       1286   1290       {ECO:0000244|PDB:3SWH}.
FT   HELIX      1293   1320       {ECO:0000244|PDB:3SWH}.
FT   HELIX      1322   1337       {ECO:0000244|PDB:3SWH}.
FT   HELIX      1353   1378       {ECO:0000244|PDB:3SWH}.
FT   HELIX      1381   1402       {ECO:0000244|PDB:3SWH}.
FT   STRAND     1454   1456       {ECO:0000244|PDB:3SWH}.
FT   HELIX      1472   1487       {ECO:0000244|PDB:3SWH}.
FT   HELIX      1488   1490       {ECO:0000244|PDB:3SWH}.
FT   HELIX      1495   1499       {ECO:0000244|PDB:3SWH}.
FT   HELIX      1502   1513       {ECO:0000244|PDB:3SWH}.
SQ   SEQUENCE   1735 AA;  196356 MW;  BFE7D0467D258900 CRC64;
     MSLLCVGVKK AKFDGAQEKF NTYVTLKVQN VKSTTIAVRG SQPSWEQDFM FEINRLDLGL
     TVEVWNKGLI WDTMVGTVWI PLRTIRQSNE EGPGEWLTLD SQAIMADSEI CGTKDPTFHR
     ILLDAHFELP LDIPEEEARY WAKKLEQLNA MRDQDEYSFQ DQQDKPLPVP SSQCCNWNYF
     GWGEQNDDPD SAVDDRDSDY RSETSNSIPP PYYTTSQPNA SVHQYSVRPP PLGSRESYSD
     SMHSYEEFSE PRALSPTGSS RYASSGELSQ GSSQLSEDFD PDEHSLQGSE LDDERDRDSY
     HSCHSSVSYH KDSPRWDQDE EDLEDLEDLE DEELPEEEEL EEEELEEEEE LEEEELELEE
     EEEVPDDLAS YTQQEDTTVA EPKEFKRISF PTAAPQKEDK VSAVPIEAPD VSKGIPKAAT
     PEEKAAAECA QEAEPPKSEE SFRSREAEEG QEGQDAMSRA KANWLRAFNK VRMQLQEARG
     EGEMSKSLWF KGGPGGGLII IDSMPDIRKR KPIPLVSDLA MSLVQSRKAG ITSALASSTL
     NNEELKNHVY KKTLQALIYP ISCTTPHNFE VWTATTPTYC YECEGLLWGI ARQGMRCTEC
     GVKCHEKCQD LLNADCLQRA AEKSSKHGAE DRTQNIIMVL KDRMKIRERN KPEIFELIQE
     VFAVTKSAHT QQMKAVKQSV LDGTSKWSAK ISITVVCAQG LQAKDKTGSS DPYVTVQVGK
     TKKRTKTIYG NLNPVWEENF HFECHNSSDR IKVRVLDEDD DIKSRVKQRF KRESDDFLGQ
     TIIEVRTLSG EMDVWYNLDK RTDKSAVSGA IRLHISVEIK GEEKVAPYHV QYTCLHENLF
     HFVTDVQNNG VVKIPDAKGD DAWKVYYDET AQEIVDEFAM RYGVESIYQA MTHFACLSSK
     YMCPGVPAVM STLLANINAY YAHTTASTNV SASDRFAASN FGKERFVKLL DQLHNSLRID
     LSMYRNNFPA SSPERLQDLK STVDLLTSIT FFRMKVQELQ SPPRASQVVK DCVKACLNST
     YEYIFNNCHE LYGREYQTDP AKKGEVPPEE QGPSIKNLDF WSKLITLIVS IIEEDKNSYT
     PCLNQFPQEL NVGKISAEVM WSLFAQDMKY AMEEHDKHRL CKSADYMNLH FKVKWLYNEY
     VAELPTFKDR VPEYPAWFEP FVIQWLDENE EVSRDFLHGA LERDKKDGFQ QTSEHALFSC
     SVVDVFSQLN QSFEIIKKLE CPDPQIVGHY MRRFAKTISN VLLQYADIVS KDFASYCSKE
     KEKVPCILMN NTQQLRVQLE KMFEAMGGKE LDAEASGTLK ELQVKLNNVL DELSHVFATS
     FQPHIEECVR QMGDILSQVK GTGNVPASAC SSVAQDADNV LQPIMDLLDS NLTLFAKICE
     KTVLKRVLKE LWKLVMNTME RTIVLPPLTD QTMIGTLLRK HGKGLEKGRV KLPSHSDGTQ
     MIFNAAKELG QLSKLKDHMV REEAKSLTPK QCAVVELALD TIKQYFHAGG VGLKKTFLEK
     SPDLQSLRYA LSLYTQATDL LIKTFVQTQS AQVHGGKGTR FTLSEDVCPE MGSGVEDPVG
     EVSVHVELFT HPGTGEQKVT VKVVAANDLK WQTSGIFRPF IEVNIVGPQL SDKKRKFATK
     SKNNSWAPKY NESFQFSLSA DAGPECYELQ VCVKDYCFAR EDRTVELAVL QLRELAQRGS
     AACWLPLGRR IHMDDTGLTV LRILSQRSND EVAKEFVKLK SDTRSAEEGG AAPAP
//
